FirstNarration
Healthcare professionals working to improve health equity may find useful lessons in the relationship building and communication strategies used by pharmaceutical sales representatives. The comparison draws attention to how certain professional approaches that have proven effective in one healthcare context might transfer to another, particularly in building trust and influencing practice patterns among medical professionals.
The Core Argument
Pharmaceutical sales representatives have developed specific methods for engaging physicians, establishing credibility, and encouraging behaviour change. These methods centre on relationship building, understanding individual provider needs, presenting evidence in accessible formats, and maintaining consistent contact over time. Health equity champions, people working to reduce disparities in healthcare access and outcomes, face similar challenges in persuading healthcare systems and individual practitioners to adopt new practices or change existing approaches.
The comparison is not about selling products. It focuses instead on the communication techniques and strategic thinking that pharmaceutical representatives use to influence clinical decision making. These include identifying key decision makers, tailoring messages to specific audiences, using data to support recommendations, and building long term professional relationships rather than expecting immediate results.
What the Strategies Involve
Pharmaceutical sales professionals typically begin by researching their audience, understanding what motivates individual physicians, what challenges they face in their practice, and what kinds of evidence they find most persuasive. They present information repeatedly and in different formats, recognizing that changing practice patterns requires sustained effort rather than a single conversation.
Health equity work often requires similar persistence. Convincing a hospital system to implement screening for social determinants of health, for example, or persuading individual clinicians to adopt culturally appropriate communication practices, involves understanding institutional barriers, addressing specific concerns, and demonstrating benefits in terms that resonate with the people being asked to change.
The strategies also emphasize meeting people where they are. Pharmaceutical representatives do not typically lecture physicians about what they should be doing. Instead, they listen to current practices, acknowledge constraints such as time pressure or budget limitations, and position their recommendations as solutions to problems the physician already recognizes. Health equity advocates can apply the same approach by framing equity interventions not as moral obligations imposed from outside, but as practical responses to challenges healthcare providers already face, such as poor health outcomes in certain patient populations or high rates of hospital readmission.
Potential Concerns and Limitations
The comparison has obvious limitations. Pharmaceutical sales operates within a commercial framework where the ultimate goal is profit, and the industry has a well documented history of problematic practices, including overstating benefits, downplaying risks, and creating conflicts of interest. Health equity work, by contrast, aims to address systemic injustice and improve population health without a profit motive.
Borrowing tactics from pharmaceutical sales does not mean adopting its ethical framework. The suggestion is to learn from what works in terms of communication and influence, while maintaining the integrity and purpose of health equity efforts. The risk is that adopting sales like approaches could undermine trust or make equity work appear transactional rather than rooted in justice and evidence.
Why This Matters
Health equity remains an urgent challenge across healthcare systems globally. Disparities in access to care, quality of treatment, and health outcomes persist along lines of income, geography, ethnicity, and other social factors. Addressing these disparities requires changing how healthcare is delivered, which in turn requires changing the behaviour of institutions and individuals.
Many health equity initiatives struggle not because the underlying evidence is weak, but because implementation is difficult. Clinicians may be sympathetic to equity goals but unsure how to act on them within the constraints of their daily practice. Administrators may support equity in principle but hesitate to commit resources without clear demonstration of benefit. Learning from fields that have successfully influenced healthcare behaviour, even fields with different motivations, could help equity advocates become more effective.
The approach also acknowledges that good intentions are not enough. Health equity champions often have deep knowledge of disparities and strong commitment to change, but may lack training in the practical work of persuasion, negotiation, and sustained engagement that drives institutional change. Recognizing that these are learnable skills, and that other fields have developed them, opens the possibility of more strategic and ultimately more successful equity work.
This remains a developing conversation rather than an established practice. Whether the comparison proves useful will depend on how thoughtfully the lessons are applied and whether they lead to measurable improvements in equity outcomes without compromising the ethical foundation of the work.
